These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 4447892

  • 1. Serum calcium, phosphate and alkaline phosphatase and morphometric bone examinations in 30 patients with renal insufficiency.
    Duursma SA, Visser WJ, Mees EJ, Njio L.
    Calcif Tissue Res; 1974; 16(2):129-38. PubMed ID: 4447892
    [No Abstract] [Full Text] [Related]

  • 2. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
    Offermann G, Schaefer K, Schulz A, Delling G.
    Klin Wochenschr; 1976 Jul 01; 54(13):625-32. PubMed ID: 940299
    [Abstract] [Full Text] [Related]

  • 3. Hypophosphataemia and osteomalacia in haemodialysis patients not taking phosphate binders.
    Ahmed KY, Varghese Z, Meinhard EA, Baillod RA, Skinner RK, Wills MR, Moorhead JF.
    Adv Exp Med Biol; 1977 Jul 01; 81():581-90. PubMed ID: 899942
    [No Abstract] [Full Text] [Related]

  • 4. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.
    Malluche HH, Faugere MC, Fanti P, Price PA.
    Kidney Int; 1984 Dec 01; 26(6):869-74. PubMed ID: 6335905
    [Abstract] [Full Text] [Related]

  • 5. 1alpha-Hydroxycholecalciferol in renal osteodystrophy.
    Pierides AM, Ellis HA, Ward MK, Simpson W, Kerr DN.
    Calcif Tissue Res; 1977 May 01; 22 Suppl():105-11. PubMed ID: 912511
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Renal osteodystrophy in non-dialysed patients with chronic renal failure.
    Andresen J, Nielsen HE.
    Acta Radiol Diagn (Stockh); 1980 May 01; 21(6):803-6. PubMed ID: 7234496
    [Abstract] [Full Text] [Related]

  • 10. Serum hydroxyproline and renal osteodystrophy in patients maintained on haemodialysis.
    Goulding A, McChesney R, Irvine RO, Dixon SR.
    N Z Med J; 1974 Dec 25; 80(530):540-4. PubMed ID: 4615274
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
    Fournier A, Bordier P, Gueris J, Sebert JL, Marie P, Ferrière C, Bedrossian J, DeLuca HF.
    Kidney Int; 1979 Feb 25; 15(2):196-204. PubMed ID: 513484
    [No Abstract] [Full Text] [Related]

  • 13. [Serum calcium, phosphorus and alkaline phosphatase as indicators in the therapy of renal osteodystrophy].
    Labos I, Kovacević M.
    Med Arh; 1988 Feb 25; 42(4):181-5. PubMed ID: 3270761
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of renal osteodystrophy with 1alpha-hydroxycholecalciferol (1alpha-OH-D3) in conjunction with a high dialysate calcium.
    Winney RJ, Bone JM, Anderson TJ, Robson JS.
    Calcif Tissue Res; 1977 May 25; 22 Suppl():94-100. PubMed ID: 912593
    [No Abstract] [Full Text] [Related]

  • 15. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA, Libbey NP, London MR, Pono L, Abuelo JG.
    Clin Nephrol; 1991 Feb 25; 35(2):78-85. PubMed ID: 2019018
    [Abstract] [Full Text] [Related]

  • 16. Plasma hydroxyproline in renal osteodystrophy.
    Varghese Z, Moorhead JF, Tatler GL, Baillod RA, Wills MR.
    Proc Eur Dial Transplant Assoc; 1973 Feb 25; 10(0):187-96. PubMed ID: 4802560
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A, Oprisiu R, Hottelart C, Yverneau PH, Ghazali A, Atik A, Hedri H, Said S, Sechet A, Rasolombololona M, Abighanem O, Sarraj A, El Esper N, Moriniere P, Boudailliez B, Westeel PF, Achard JM, Pruna A.
    Artif Organs; 1998 Jul 25; 22(7):530-57. PubMed ID: 9684690
    [Abstract] [Full Text] [Related]

  • 20. The treatment of renal osteodystrophy with 1-alpha-hydroxycholecalciferol.
    Junor BJ, Catto GR, Macleod M.
    Calcif Tissue Res; 1977 May 25; 22 Suppl():112-6. PubMed ID: 912512
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.